(Q42705046)

5 November 2017

title

Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice (English)

1 reference

5 November 2017

Xia Cao

1

1 reference

5 November 2017

Tao Luo

series ordinal

2

1 reference

5 November 2017

Xi Luo

series ordinal

3

1 reference

5 November 2017

Zhiyi Tang

series ordinal

4

1 reference

5 November 2017

publication date

26 June 2014

1 reference

5 November 2017

published in

Hypertension Research

1 reference

5 November 2017

volume

37

1 reference

5 November 2017

issue

9

1 reference

5 November 2017

page(s)

803-810

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2014.90

5 November 2017

exact match

0 references

cites work

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Global burden of blood-pressure-related disease, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Fifty years of Framingham Study contributions to understanding hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Central administration of resveratrol improves diet-induced diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Statins activate AMP-activated protein kinase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Rho/Rho-kinase mediated signaling in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Rho kinases in cardiovascular physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Rho GTPases and their effector proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

AMPK in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

AMP-activated protein kinase, super metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

inferred from DOI database lookup

7 January 2021

based on heuristic

Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

inferred from DOI database lookup

7 January 2021

based on heuristic

Rho GTPases and their effector proteins

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.90

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/HR.2014.90

1 reference

Dimensions Publication ID

5 November 2017

1032583862

0 references

1 reference